Torthaí cuardaigh - Eveline Barbieri

  • 1 - 9 toradh as 9 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo

    Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo de réir Zaowen Chen, Yunfu Lin, Eveline Barbieri, Sue Burlingame, John Hicks, Andrew D. Ludwig, Jason M. Shohet

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death

    MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death de réir Eveline Barbieri, Parth S. Mehta, Zaowen Chen, Linna Zhang, Andrew Slack, Stacey L. Berg, Jason M. Shohet

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

    Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma de réir Agarwal, Saurabh, Milazzo, Giorgio, Rajapakshe, Kimal, Bernardi, Ronald, Chen, Zaowen, Eveline, Barbieri, Koster, Jan, Perini, Giovanni, Coarfa, Cristian, Shohet, Jason M.

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma

    The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma de réir Anna Lakoma, Eveline Barbieri, Saurabh Agarwal, Jeremy R. Jackson, Z Chen, Yong Ho Kim, Matthew C. McVay, Jason M. Shohet, Eugene S. Kim

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma

    A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma de réir Jason M. Shohet, Rajib Ghosh, Cristian Coarfa, Andrew D. Ludwig, Ashley Benham, Zaowen Chen, Danielle Patterson, Eveline Barbieri, Pieter Mestdagh, Denae N. Sikorski, Aleksandar Milosavljevic, Eugene S. Kim, Preethi H. Gunaratne

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

    Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma de réir Eveline Barbieri, Katleen De Preter, Mario Capasso, Zaowen Chen, Danielle M. Hsu, Gian Paolo Tonini, Steve Lefever, John Hicks, Rogier Versteeg, Andrea Pession, Frank Speleman, Eugene S. Kim, Jason M. Shohet

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic

    G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic de réir Danielle M. Hsu, Saurabh Agarwal, Ashley Benham, Cristian Coarfa, Denae N. Trahan, Zaowen Chen, Paris N. Stowers, Amy N. Courtney, Anna Lakoma, Eveline Barbieri, Leonid S. Metelitsa, Preethi H. Gunaratne, Eugene S. Kim, Jason M. Shohet

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Restoration of the molecular clock is tumor suppressive in neuroblastoma

    Restoration of the molecular clock is tumor suppressive in neuroblastoma de réir Myrthala Moreno‐Smith, Giorgio Milazzo, Ling Tao, Baharan Fekry, Bokai Zhu, Mahmoud A. Mohammad, Simone Di Giacomo, Roshan M. Borkar, Karthik Reddy Kami Reddy, Mario Capasso, Sanjeev A. Vasudevan, Pavel Sumazin, John Hicks, Nagireddy Putluri, Giovanni Perini, Kristin Eckel‐Mahan, Thomas P. Burris, Eveline Barbieri

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma

    MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma de réir Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, Myrthala Moreno‐Smith, Tajhal D. Patel, Barry Zorman, Andrew Badachhape, Blanca E. Hernandez, Amber B. Wolf, Zihua Zeng, Jennifer H. Foster, Sara Aloisi, Pavel Sumazin, Youli Zu, John Hicks, Ketan B. Ghaghada, Nagireddy Putluri, Giovanni Perini, Cristian Coarfa, Eveline Barbieri

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: